MedShift: Medical Technology Company Raises $108 Million

By Annie Baker • Apr 27, 2023

Leading medical technology company MedShift announced it has completed a $108 million capital raise from Turning Rock Partners, Micota Capital, and OY6 Capital. The compilation facility solidifies MedShift’s industry value and propels advancements across the company’s 3 primary technologies: Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service).

MedShift has been at the forefront of developing technology solutions that serve a broad range of medical device manufacturers and practitioners across the Dermatology, Gynecology, Plastic Surgery, and MedSpa market. And the company’s value proposition is unique in that it combines its expertise in designing, deploying, and maintaining innovative technology solutions for medical device manufacturers with a range of complementary products and services.

The company’s mission is to drive business transformation and power sales through the use of modern technology. And MedShift company currently has partnered with 25 aesthetic manufacturers and distributors, a portfolio of 80+ devices, and over 2,000 active medical providers.

KEY QUOTES:

“The continued validation of MedShift’s holistic market offerings is very exciting to witness. Continued profitable growth was a catalyst to securing this raise, and the entire team executed flawlessly through wildly shifting market conditions to successfully complete the transaction. I look forward to the accelerated delivery of cutting-edge solutions to industry and practitioner partners this facility will support.”

  • Brian Phillips, Executive Chairman and Co-Founder of MedShift

“We are excited about the future of MedShift and the impact we can make on the healthcare industry. With MedShift, we aim to enrich aesthetic medical device manufacturers with high-quality, high-performing solutions that have the power to transform their business operations and help them achieve their goals. This additional funding will allow us to work towards fulfilling a significant unmet need.”

  • Joe Gasque, Chief Executive Officer of MedShift